alisporivir (DEB-025) - Debiopharm, Solid BioSciences
Deutsche Bank Securities Healthcare Conference (Novartis) - May 3, 2011 - alisporovir (DEB-025) / Novartis; Anticipated US launch for HCV infection from 2011-16 
Anticipated US launch • Hepatitis C Virus
http://www.larvolonline.com/tlg/ccdb/NovartisDeutscheBankSecuritiesHealthCareConferenceMay3.pdf
 
May 3, 2011
 
 
d94fe4e6-86ea-4d5e-aa94-390c039fa835.png